home.social

#mdmaassistedtherapy — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #mdmaassistedtherapy, aggregated by home.social.

fetched live
  1. pubmed.ncbi.nlm.nih.gov/395314 Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model (Stanicic, et al, 2024) #mdma #mdmaassistedtherapy #mdmaassistedpsychotherapy #psychedelic #psychedelics #mentalhealth #psychedelicmentalhealth

  2. What #psychedelics are available for #psychedelicassistedpsychotherapy now that the #fda rejected one company's application for #mdmaassistedtherapy for #ptsd? Generic, racemic #ketamine with many other molecules in various FDA-approved phases of development for many #mentalhealth indications. For use in collaboration with your medical and mental health care providers. psychedelicmentalhealth.net/wh

  3. pubmed.ncbi.nlm.nih.gov/388969 The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials (Yang, et al, 2024) #mdma #fda #psychedelic #psychedelics #fda #psychedelicresearch #MDMAtherapy #mdmaassistedtherapy #ptsd #psychedelictherapy #psychedelicassistedpsychotherapy #neuroscience #psychiatry #mentalhealth — Adverse effects found not to interfere with efficacy

  4. pubmed.ncbi.nlm.nih.gov/389577 Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System (Makunts, et al, 2024) #mdma #dili #liver #psychedelic #psychedelicresearch #faers #fda #psychedelics #mdmaassistedtherapy — finding in estimated 20 million, perhaps 1 case of liver damage from MDMA, increased risk with poly drug use.

  5. clinicaltrials.gov/study/NCT05 Emory University plans #fda Phase 2 study of #mdma plus a type of behavioral #psychotherapy called Exposure Therapy for the treatment of #ptsd — This study is unrelated to the MAPS/Lykos new drug application for #mdmaassistedtherapy and a reminder #psychedelic #research is robust and ongoing. #studydesign should include blinding with #ketamine and comparison to #cognitivebehavioraltherapy #psychedelics

  6. @jeztastic cite your sources. I’ve cited mine. If you want to do a multi-year, full-time lit review on how cbt is not effective, and is not evidence-based, feel free. It has been studied, with and without psych meds and psychedelics, and offers better study design than whatever Lykos presented for #mdmaassistedtherapy

  7. One member of the FDA advisory committee, and non-voting, industry rep worked on Spravato for Jansen. Her colleague, a psychiatrist was MAPS-trained and works with ketamine currently. Let’s talk conflict of interests. What #psychiatricmedicines have been tested against the gold standard of cognitive behavioral therapy? Which of the providers in the #mdmaassistedtherapy trials or advisory meeting actually practice CBT? #studydesign #litreview #contactus

  8. pubmed.ncbi.nlm.nih.gov/387735 Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial
    (Bhagavan et al. Trials. 2024) Note: Scientific clinical trials are not the same as mental health treatment. #mdma #mdmaassistedtherapy #newzealand #deathanxiety #depression #oncology #anxiety #depression #psychedelic #psychedelicresearch #oncology #psychedelicassistedpsychotherapy

  9. (#wapo #GiftLink below)

    I am a big supporter of psychedelic based therapies, including #MDMA. I think MDMA will be a component of future PTSD treatment.

    Yet, I'm VERY happy with the advisory board's decision to say no. The company, Lykos Therapeutics, simply can't be trusted in this space. I would encourage the #FDA to follow the advice of the committee.

    #psychedelics #psychedelicmedicine #ptsd #ptsdhealth #mdmaassistedtherapy

    wapo.st/4ea3pqj

  10. (#wapo #GiftLink below)

    I am a big supporter of psychedelic based therapies, including #MDMA. I think MDMA will be a component of future PTSD treatment.

    Yet, I'm VERY happy with the advisory board's decision to say no. The company, Lykos Therapeutics, simply can't be trusted in this space. I would encourage the #FDA to follow the advice of the committee.

    #psychedelics #psychedelicmedicine #ptsd #ptsdhealth #mdmaassistedtherapy

    wapo.st/4ea3pqj